Bristol-Myers Squibb (BMY) Tops Q4 EPS by 5c, Offers FY Guidance
Get Alerts BMY Hot Sheet
Price: $44.70 -8.51%
EPS Growth %: -314.6%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -314.6%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $1.46, $0.05 better than the analyst estimate of $1.41. Revenue for the quarter came in at $11.07 billion versus the consensus estimate of $10.73 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2021 EPS of $7.35-$7.55, versus the consensus of $7.45.
- Bristol Myers Squibb is providing 2021 GAAP EPS guidance in the range of $3.12-$3.32 and is increasing its non-GAAP EPS guidance range from $7.15 - $7.45 to $7.35 - $7.55. Both GAAP and non-GAAP guidance assume current exchange rates. Key 2021 GAAP and non-GAAP line item guidance assumptions are:
- Worldwide revenues increasing in the high-single digits.
- Gross margin as a percentage of revenue to be approximately 80.5%.
- Marketing, selling and administrative expenses to be in-line with 2020 levels for GAAP and increasing in the low-single digit range for non-GAAP.
- Research and development expenses decreasing in the high-single digits for GAAP and increasing in the mid-single digits for non-GAAP.
- An effective tax rate of approximately 22% for GAAP and approximately 16% for non-GAAP.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
- Juniper Networks (JNPR) Misses Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!